Title: Letavic MA, et al. 4-Methyl-6,7-dihydro-4H-triazolo,5-cpyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate. Send to
115880-04-1 | Acetic acid, 2-(4-phenylcyclohexylidene)-, ethyl ester | AA000GYY | MFCD13181210
1283718-31-9 | Methyl 2-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline-6-carboxylate | AA000XXQ | MFCD16251071
1632285-92-7 | 1-(2-Amino-4,6-difluorophenyl)ethanone | AA001TT9 | MFCD27923708
230615-70-0 | 1-(9,10-Dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)-2,2,2-trifluoroethanone | AA002LZK | MFCD23701601
6738-27-8 | 2,6-Di-tert-butyl-4-ethylidenecyclohexa-2,5-dienone | AA0038F7 | MFCD28972399
885269-66-9 | 6-Methyl-1h-pyrazolo[3,4-b]pyridine | AA00471P | MFCD08234559
956086-95-6 | 2-MERCAPTOPYRIMIDINE-4,6-DIOL | AA006C9Q | MFCD00044705
111726-46-6 | 2-Iodo-6-methoxyphenol | AA007S7Z | MFCD11054827
1037210-93-7 | IPI-926 | AA009243 | MFCD20526655
1160653-95-1 | 3-bromo-2-fluoro-6-hydroxybenzaldehyde | AA009M08 | MFCD15528068